I'm LongbridgeAI, I can summarize articles.As tech giants tighten their grip, niche players are recalibrating strategies. eBay Inc. (EBAY.US) rebuffed GameStop's $55.5B hostile takeover bid led by Ryan Cohen, while navigating UK antitrust scrutiny over its Depop acquisition. Amazon's new cross-platform seller tools add competitive pressure just as the stock trades near 52-week lows.
AAON Inc. (AAON.US) emerges as an AI infrastructure beneficiary with $2.13B in cooling system backlogs, Basx division revenue surging 61.5% YoY. TNL Mediagene (TNMG.US) exits Japan through a $5.5M management buyout, signaling strategic refocusing amid regional market shifts.
Biotech narratives diverge: Arrowhead Pharmaceuticals (ARWR.US) prepares tau-targeting Alzheimer's data, while Nektar Therapeutics (NKTR.US) saw shares plunge 22% despite positive alopecia results. SELLAS Life Sciences (SLS.US) filed a $154.6M shelf offering ahead of pivotal oncology trials.
AngloGold Ashanti (AU.US) maintains 3M-ounce gold output targets with $2B buybacks, contrasting with Advasa (ADBT.US) microcap volatility. USGG.US, a long-duration Treasury ETF, shows muted flows amid Fed policy uncertainty.